Medcot SPRL
The score of Medcot shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -31 % Total assets -25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medcot's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 06 Oct 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Medcot's financial analysis
- Solvency54.1%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medcot
Medcot's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0864.439.947
- VAT number
- BE0864439947
- Peppol
- Registered · 0208:0864439947 · as of 09 Nov 2026
- Legal form
- SPRL
- Incorporated
- 31 Mar 2004
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Medcot (SPRL) has been based in Waterloo since 2004, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 225 € and equity of 293,775 €; its revenue is not published. Its solvency stands at 54.1%, below the median of its sector (58.2%).
Companies similar to Medcot
Companies in the same business, of comparable size and area, outside its group.
- Pharmaplex Research and experimental development on natural sciences and engineering Wezembeek-Oppem · balance sheet 482,967 €
- Susty Wastes Solutions Research and experimental development on natural sciences and engineering Blegny · balance sheet 548,782 €
- MethodX Research and experimental development on natural sciences and engineering Waterloo · balance sheet 509,257 €
- Soetemont Consulting Research and experimental development on natural sciences and engineering Uccle · balance sheet 628,120 €
- Cabinet Grumbers Research and experimental development on natural sciences and engineering Lessines · balance sheet 642,094 €
- Brai3N Business and other management consultancy activities Ghent · balance sheet 973,363 €
- Zinc Consult Business and other management consultancy activities Brussels · balance sheet 651,183 €
- Transversality Research and experimental development on natural sciences and engineering Evere · balance sheet 293,152 €
Frequently asked questions about Medcot
What is the revenue of Medcot?
Medcot files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medcot?
In Belgium, the VAT number is the company number prefixed with BE: BE0864439947 for Medcot, if the company is VAT-registered. Its company number (CBE) is 0864.439.947.
Where is the registered office of Medcot?
According to the CBE register, the registered office of Medcot is in 1410 Waterloo.
What is the equity of Medcot?
At the close of the 2025 financial year, the equity of Medcot amounts to 293,775 €, a solvency of 54.1% of total assets.
Who manages Medcot?
The register lists 1 active mandates at Medcot. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medcot
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →